WB01
/ Wrench Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
Targeting IL-18BP-mediated adaptive resistance with WB01 restores endogenous IL-18 activity and enhances checkpoint inhibitor efficacy
(SITC 2026)
- No abstract available
Checkpoint inhibition • Clinical • Oncology • IL18
1 to 1
Of
1
Go to page
1